Cargando…
Photoimmunotherapy for Managing Recurrent Laryngeal Cancer Cervical Lesions: A Case Report
Photoimmunotherapy (PIT) targets and destroys tumor cells through irradiation with 690-nm red light after the administration of cetuximab sarotalocan sodium, which contains IRDye700DX bound to cetuximab. In Japan, PIT is a new treatment that is covered by insurance only for unresectable head and nec...
Autores principales: | Okamoto, Isaku, Okada, Takuro, Tokashiki, Kunihiko, Tsukahara, Kiyoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832182/ https://www.ncbi.nlm.nih.gov/pubmed/35221967 http://dx.doi.org/10.1159/000521435 |
Ejemplares similares
-
Quality-of-Life Evaluation of Patients with Unresectable Locally Advanced or Locally Recurrent Head and Neck Carcinoma Treated with Head and Neck Photoimmunotherapy
por: Okamoto, Isaku, et al.
Publicado: (2022) -
A Case of Oropharyngeal Carcinoma with an Oblique Neck that Benefited from Transoral Robotic Surgery
por: Yamakura, Tatsuya, et al.
Publicado: (2023) -
Postoperative Complications and Swallowing Function after Jejunal and Skin Flap Reconstruction for Hypopharyngeal Carcinoma—A Multicenter Retrospective Study
por: Tokashiki, Kunihiko, et al.
Publicado: (2022) -
A Case of Primary Submandibular Gland Oncocytic Carcinoma
por: Tokashiki, Kunihiko, et al.
Publicado: (2013) -
Single-center prospective study on the efficacy of nivolumab against platinum-sensitive recurrent or metastatic head and neck squamous cell carcinoma
por: Okamoto, Isaku, et al.
Publicado: (2022)